FDA Reopens Comment Period for Direct-to-Consumer Promotion of Prescription Drugs

Summary

The Food and Drug Administration (FDA) is extending the public comment period for two proposed information collections, including surveys of physicians and patients, until June 5, 2001, to assess the impact of direct-to-consumer marketing of prescription medications.